Status:
ENROLLING_BY_INVITATION
Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes
Lead Sponsor:
JuFeng, Hsiao
Collaborating Sponsors:
Lotung Poh-Ai Hospital
Conditions:
Type2 Diabetes
Coronary Heart Disease
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
To evaluate benefits of primary prevention of major coronary heart disease for asymptomatic coronary artery disease in type 2 diabetes mellitus based on the coronary artery calcium score Our proposal ...
Detailed Description
Background The patients with type two diabetes mellites increased gradually and heart disease and cerebral vascular disease is the fourth leading cause of mortality. According to the National Health I...
Eligibility Criteria
Inclusion
- more than 40 years old T2DM patients have any one cardiovascular risk as follows
- total cholesterol\>200mg/dl or low density lipoprotein (LDL) \>100mg/dl
- blood pressure\>140/90mm/Hg or taking anti-hypertension agents
- history of smoking
- family history of early coronary heart diseases
- proteinuria
Exclusion
- history of cardiovascular diseases such as coronary heart disease, stroke, heart failure etc, pregnant
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05267990
Start Date
March 1 2022
End Date
December 31 2028
Last Update
May 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lo-Tung Poh-Ai Hospital
Yilan, Taiwan, 26546